May 20, 2014 Dear Senator, Pfizer – America’s largest drug maker – has made headlines recently over its attempt to acquire a smaller foreign competitor that would allow it to avoid U.S. taxes by becoming a “forei - Corporate inversion - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2014-05-20 15:27:45 International taxation Offshore finance Economics Anti-globalization Tax haven Public economics Corporate tax Corporate inversion Pfizer Tax avoidance Business Finance		May 20, 2014 Dear Senator, Pfizer – America’s largest drug maker – has made headlines recently over its attempt to acquire a smaller foreign competitor that would allow it to avoid U.S. taxes by becoming a “forei Add to Reading List Source URL: thefactcoalition.org Download Document from Source Website File Size: 46,89 KB Share Document on Facebook

	CTJ Citizens for Tax Justice COMMENTS TO THE U.S. TREASURY DEPARTMENT AND THE INTERNAL DocID: 1qd0V - View Document
	Internal Revenue Service Attention: CC:PA:LPD:PR (REGWashington, DCVia: http://www.regulations.gov Re: IRSTo whom it may concern: DocID: 1pd7j - View Document
	M&A From shareholder reactions and activist attacks to inversion opportunities and other strategic options, Bank of America Merrill Lynch (BofAML) senior bankers address commonly asked questions DocID: 1oKc8 - View Document
	Internal Revenue Service Attention: CC:PA:LPD:PR (REGWashington, DCVia: http://www.federalregister.gov Re: IRSTo whom it may concern: DocID: 1onLt - View Document
	May 20, 2014 Dear Senator, Pfizer – America’s largest drug maker – has made headlines recently over its attempt to acquire a smaller foreign competitor that would allow it to avoid U.S. taxes by becoming a “forei DocID: 11iB0 - View Document